Market Cap

CellSeed, Inc. Market Capitalization:

¥10.78 Billion

JPY as of Jan. 1, 2026

US$68.8 Million

business CellSeed, Inc. Company Profile

CellSeed, Inc. Main Stock Listing

JPX: 7776

Market Capitalization History of CellSeed, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of CellSeed, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 ¥10.78 B -33.78%
Jan. 1, 2025 ¥16.28 B 94.08%
Jan. 1, 2024 ¥8.39 B 77.43%
Jan. 1, 2023 ¥4.73 B 91.56%
Jan. 1, 2022 ¥2.47 B -38.40%
Jan. 1, 2021 ¥4.01 B -47.26%
Jan. 1, 2020 ¥7.60 B -54.11%
Jan. 1, 2019 ¥16.55 B 102.55%
Jan. 1, 2018 ¥8.17 B -8.77%
Jan. 1, 2017 ¥8.96 B -8.66%
Jan. 1, 2016 ¥9.81 B -36.84%
Jan. 1, 2015 ¥15.53 B -52.03%
Jan. 1, 2014 ¥32.37 B 110.42%
Jan. 1, 2013 ¥15.38 B 6.08%
Jan. 1, 2012 ¥14.50 B -54.25%
Jan. 1, 2011 ¥31.70 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

CellSeed, Inc. Categories

Japan languages Healthcare languages Biotechnology
Japan Healthcare Japan Biotechnology

Stocks & Indices

CellSeed, Inc. has the following listings and related stock indices.


Stock: JPX: 7776

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.